Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Insights into molecular mechanism of action of salan titanium(IV) complex with in vitro and in vivo anticancer activity.

Miller M, Braitbard O, Hochman J, Tshuva EY.

J Inorg Biochem. 2016 Oct;163:250-257. doi: 10.1016/j.jinorgbio.2016.04.007.

PMID:
27090292
2.

Specific Design of Titanium(IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents.

Meker S, Braitbard O, Hall MD, Hochman J, Tshuva EY.

Chemistry. 2016 Jul 11;22(29):9986-95. doi: 10.1002/chem.201601389.

PMID:
27320784
3.

Intraocular Lymphoma Models.

Aronow ME, Shen D, Hochman J, Chan CC.

Ocul Oncol Pathol. 2015 Apr;1(3):214-22. doi: 10.1159/000370158. Review.

4.

A new immunization and treatment strategy for mouse mammary tumor virus (MMTV) associated cancers.

Braitbard O, Roniger M, Bar-Sinai A, Rajchman D, Gross T, Abramovitch H, La Ferla M, Franceschi S, Lessi F, Naccarato AG, Mazzanti CM, Bevilacqua G, Hochman J.

Oncotarget. 2016 Apr 19;7(16):21168-80. doi: 10.18632/oncotarget.7762.

5.

Highly Effective and Hydrolytically Stable Vanadium(V) Amino Phenolato Antitumor Agents.

Reytman L, Braitbard O, Hochman J, Tshuva EY.

Inorg Chem. 2016 Jan 19;55(2):610-8. doi: 10.1021/acs.inorgchem.5b02519.

PMID:
26699515
6.

Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity.

Meker S, Braitbard O, Margulis-Goshen K, Magdassi S, Hochman J, Tshuva EY.

Molecules. 2015 Oct 9;20(10):18526-38. doi: 10.3390/molecules201018526.

7.

Human saliva as route of inter-human infection for mouse mammary tumor virus.

Mazzanti CM, Lessi F, Armogida I, Zavaglia K, Franceschi S, Al Hamad M, Roncella M, Ghilli M, Boldrini A, Aretini P, Fanelli G, Marchetti I, Scatena C, Hochman J, Naccarato AG, Bevilacqua G.

Oncotarget. 2015 Jul 30;6(21):18355-63.

8.

Central nervous system acute lymphoblastic leukemia: role of natural killer cells.

Frishman-Levy L, Shemesh A, Bar-Sinai A, Ma C, Ni Z, Frenkel S, Muench V, Bruckmueller H, Vokuhl C, Debatin KM, Eckert C, Stanulla M, Schrappe M, Campbell KS, Loewenthal R, Schewe DM, Hochman J, Meyer LH, Kaufman D, Cario G, Porgador A, Izraeli S.

Blood. 2015 May 28;125(22):3420-31. doi: 10.1182/blood-2014-08-595108. Erratum in: Blood. 2015 Jul 16;126(3):425.

9.

Anti-proliferative activity of nano-formulated phenolato titanium(IV) complexes against cancer cells.

Meker S, Margulis-Goshen K, Weiss E, Braitbard O, Hochman J, Magdassi S, Tshuva EY.

ChemMedChem. 2014 Jun;9(6):1294-8. doi: 10.1002/cmdc.201400038.

PMID:
24677761
10.

Anti-LFA-1 antibodies enhance metastasis of ocular lymphoma to the brain and contralateral eye.

Hochman J, Shen D, Gottesman MM, Chan CC.

Clin Exp Metastasis. 2013 Jan;30(1):91-102. doi: 10.1007/s10585-012-9512-2.

11.

The signal peptide of mouse mammary tumor virus-env: a phosphoprotein tumor modulator.

Feldman D, Roniger M, Bar-Sinai A, Braitbard O, Natan C, Love DC, Hanover JA, Hochman J.

Mol Cancer Res. 2012 Aug;10(8):1077-86. doi: 10.1158/1541-7786.MCR-11-0581.

12.

Reversing ABCB1-mediated multi-drug resistance from within cells using translocating immune conjugates.

Wellhöner H, Weiss A, Schulz A, Adermann K, Braitbard O, Bar-Sinai A, Hochman J.

J Drug Target. 2012 Jun;20(5):445-52. doi: 10.3109/1061186X.2012.685473.

PMID:
22577854
13.

Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.

Manna CM, Braitbard O, Weiss E, Hochman J, Tshuva EY.

ChemMedChem. 2012 Apr;7(4):703-8. doi: 10.1002/cmdc.201100593.

PMID:
22262543
14.

A Key role for cyclic AMP-responsive element binding protein in hypoxia-mediated activation of the angiogenesis factor CCN1 (CYR61) in Tumor cells.

Meyuhas R, Pikarsky E, Tavor E, Klar A, Abramovitch R, Hochman J, Lago TG, Honigman A.

Mol Cancer Res. 2008 Sep;6(9):1397-409. doi: 10.1158/1541-7786.MCR-07-2086.

15.

Cranberry juice constituents impair lymphoma growth and augment the generation of antilymphoma antibodies in syngeneic mice.

Hochman N, Houri-Haddad Y, Koblinski J, Wahl L, Roniger M, Bar-Sinai A, Weiss EI, Hochman J.

Nutr Cancer. 2008;60(4):511-7. doi: 10.1080/01635580801956493.

PMID:
18584485
16.

The signal peptide of the mouse mammary tumor virus Rem protein is released from the endoplasmic reticulum membrane and accumulates in nucleoli.

Dultz E, Hildenbeutel M, Martoglio B, Hochman J, Dobberstein B, Kapp K.

J Biol Chem. 2008 Apr 11;283(15):9966-76. doi: 10.1074/jbc.M705712200.

17.

International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future.

Nussenblatt RB, Chan CC, Wilson WH, Hochman J, Gottesman M; CNS and Ocular Lymphoma Workshop Group..

Ocul Immunol Inflamm. 2006 Jun;14(3):139-44. Review.

18.

Mouse mammary tumor virus Env-derived peptide associates with nucleolar targets in lymphoma, mammary carcinoma, and human breast cancer.

Bar-Sinai A, Bassa N, Fischette M, Gottesman MM, Love DC, Hanover JA, Hochman J.

Cancer Res. 2005 Aug 15;65(16):7223-30.

19.

Murine model of primary intraocular lymphoma.

Chan CC, Fischette M, Shen D, Mahesh SP, Nussenblatt RB, Hochman J.

Invest Ophthalmol Vis Sci. 2005 Feb;46(2):415-9.

20.

The leader peptide of MMTV Env precursor localizes to the nucleoli in MMTV-derived T cell lymphomas and interacts with nucleolar protein B23.

Hoch-Marchaim H, Weiss AM, Bar-Sinai A, Fromer M, Adermann K, Hochman J.

Virology. 2003 Aug 15;313(1):22-32.

Supplemental Content

Loading ...
Support Center